Status:
COMPLETED
Ozone Therapy in Ankylosing Spondylitis
Lead Sponsor:
Pamukkale University
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study was to investigate the effects of rectal ozone therapy added to medical treatment on pain severity, disease activity, spinal mobility, functional status, enthesitis, and quality ...
Eligibility Criteria
Inclusion
- Patients who were diagnosed as AS according to the Modified New York criteria
Exclusion
- having other concomitant rheumatic diseases,
- receiving anti-TNF-α therapy within the last 3 months,
- being in clinical remission with standard medical treatment,
- being pregnant,
- having diseases such as favism, asthma, pancreatitis, and uncontrolled hyperthyroidism for which ozone therapy is contraindicated.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05429801
Start Date
December 1 2018
End Date
December 30 2019
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hakan Alkan
Denizli, None Selected, Turkey (Türkiye), 20100